Daryl Murry, Pharm.D. (he/him/his)

University of Nebraska Medical Center

Poster(s):

• (M1430-10-66) Assessment of In Vitro and In Vivo Pre-clinical Pharmacokinetics of EPZ015666; a Novel Small Molecule for Medulloblastoma Treatment
  Monday, October 23, 2023

  2:30 PM – 3:30 PM ET

• (M1230-10-63) Characterization of Preclinical In Vitro and In Vivo Pharmacokinetics Properties for JNJ-64619178, a New Therapeutic for the Treatment of Medulloblastoma
  Monday, October 23, 2023

  12:30 PM – 1:30 PM ET

• (M1030-10-63) In Vitro and In Vivo Pharmacokinetics of a Novel B7-H3 Inhibitor (Ni1) for the Treatment of Group 3 Medulloblastoma
  Monday, October 23, 2023

  10:30 AM – 11:30 AM ET

• (T1430-10-65) Novel Biomarkers for Inflammatory Bowel Disease
  Tuesday, October 24, 2023

  2:30 PM – 3:30 PM ET

• (W1230-06-39) Simultaneous LC-MS/MS Method for the Quantitation of Azithromycin, Hydroxychloroquine and its Metabolites In SARS-CoV-2(-/+) Populations Using Dried Blood Spots
  Wednesday, October 25, 2023

  12:30 PM – 1:30 PM ET

• (W1130-04-27) The Effect of MO-OH-Nap Tropolone on Osteosarcoma Cellular Metabolism
  Wednesday, October 25, 2023

  11:30 AM – 12:30 PM ET